rmadesk Solutions is a consulting firm providing end to end solution for bioequivalence related requirements to generic companies around the globe. Through a portfolio of well-designed services, we support the complete bioequivalence study management cycle.Â
rmadesk provide end to end bioequivalence services to our clients, start from product feasibility to report submission and till responding regulatory queries. Our services include complete bioequivalence project management, CRO qualification & selection, design and conduct of bioequivalence studies, medical and regulatory writing services, failed biostudy investigations, clinical and bioanalytical review etc.
As Generic rmaceutical industry continues to mature and penetrate new areas, the regulatory and competitive landscape becomes more challenging. Every stage of the product life cycle needs very specific expertise and detailed understanding. Bioequivalence (BE) being one of the most important aspects of the generic product development, has always gained significant attention from the Regulatory Authorities throughout the world.Â